Last-Minute Deals Delay Argos' Ch. 11 Confirmation
Bankrupt drug developer Argos Therapeutics tentatively ducked Chapter 11 confirmation battles with its top creditors Wednesday, delaying its plan approval hearing after reaching deals to pay off a secured lender and...To view the full article, register now.
Already a subscriber? Click here to view full article